Business · 09/03/2007
FDA Approves New Animal Drugs for Heartworm Prevention and Flea Control by Bayer HealthCare LLC
The FDA is amending its regulations to reflect the approval of two new animal drug applications by Bayer HealthCare LLC, which allow for the topical use of imidacloprid and moxidectin to prevent heartworm disease, treat flea infestations, and control internal parasites in dogs and cats.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →